Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke A Study of 12 OECD Countries

This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among three pharmaceutical variables (expenditure, volume of...

Full description

Bibliographic Details
Main Author: Dickson, Michael
Other Authors: Jacobzone, Stephane
Format: eBook
Language:English
Published: Paris OECD Publishing 2003
Series:OECD Health Working Papers
Subjects:
Online Access:
Collection: OECD Books and Papers - Collection details see MPG.ReNa
LEADER 01881nma a2200253 u 4500
001 EB001831055
003 EBX01000000000000000997501
005 00000000000000.0
007 cr|||||||||||||||||||||
008 180616 ||| eng
100 1 |a Dickson, Michael 
245 0 0 |a Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke  |h Elektronische Ressource  |b A Study of 12 OECD Countries  |c Michael, Dickson and Stephane, Jacobzone 
260 |a Paris  |b OECD Publishing  |c 2003 
300 |a 79 p.  |c 21 x 29.7cm 
653 |a Social Issues/Migration/Health 
700 1 |a Jacobzone, Stephane 
041 0 7 |a eng  |2 ISO 639-2 
989 |b OECD  |a OECD Books and Papers 
490 0 |a OECD Health Working Papers 
028 5 0 |a 10.1787/237273475872 
856 4 0 |a oecd-ilibrary.org  |u https://doi.org/10.1787/237273475872  |x Verlag  |3 Volltext 
082 0 |a 304 
082 0 |a 610 
520 |a This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among three pharmaceutical variables (expenditure, volume of drug use, and unit expenditure) classified according to eight therapeutic categories which are specific for the prevention and treatment of cardiovascular disease and stroke. It covers an 11-year time period, and specifies relevant country-specific structural features in a sample of 12 OECD countries. The data presented in this report show how the three descriptive pharmaceutical variables vary across these countries. The study also contains a preliminary exploration of factors associated with variation in these variables across countries and through time. Findings for each of the eight cardiovascular disease and stroke drug therapeutic categories investigated in this study are ..